Jack O’Meara

CEO at Ochre Bio

Speaker

Jack O'Meara is Co-founder and CEO of Ochre Bio, a biotechnology company developing RNA therapies for chronic liver diseases. Using breakthroughs in genomics, computation and organ perfusion, Ochre hopes to turn the tide on one of the most pressing healthcare challenges of our time. In his role as CEO, Jack has raised over $40M from renowned global investors, built a seasoned executive team and board, and progressed a pipeline of novel RNAi medicines towards the clinic. Prior to Ochre, he worked in management consulting where he supported the global launch of Zolgensma at AveXis. Mr. O'Meara graduated technical degrees from the University of Galway, Ireland, and Notre Dame, US, and his work has appeared in the Wall Street Journal and the Financial Times.